COVID-19 Vaccination in Patients With Cancer and Recipients of Cellular Therapy.
Journal
Oncology (Williston Park, N.Y.)
ISSN: 0890-9091
Titre abrégé: Oncology (Williston Park)
Pays: United States
ID NLM: 8712059
Informations de publication
Date de publication:
24 02 2023
24 02 2023
Historique:
entrez:
2
3
2023
pubmed:
3
3
2023
medline:
7
3
2023
Statut:
ppublish
Résumé
COVID-19 continues to disproportionately affect patients with cancer because of their underlying immunocompromised state. Strategies to mitigate the impact of COVID-19 on patients with cancer include vaccination, which has demonstrated some level of protection, at least against serious complications such as respiratory failure and death, with limited safety concerns. In this narrative review, we discuss the current COVID-19 vaccines that are available in the United States, the published data regarding vaccine efficacy and safety in patients with cancer, current vaccination guidelines, and future directions.
Identifiants
pubmed: 36862845
pii: 25920985
doi: 10.46883/2023.25920985
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM